News Releases
All Releases
View Summary Peregrine Pharmaceuticals Secures $30 Million Loan Facility
Aug 30, 2012
PDF 19.6 KB Add to Briefcase
View Summary Peregrine to Present at Stifel Nicolaus Healthcare Conference September 5, 2012 at 2:40 PM EDT
Aug 29, 2012
PDF 14.5 KB Add to Briefcase
View Summary Peregrine to Present at Wedbush Securities Life Sciences Management Access Conference on August 15, 2012 at 10:55 AM EDT
Aug 8, 2012
PDF 15.5 KB Add to Briefcase
View Summary Peregrine Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement
Jul 30, 2012
PDF 13.8 KB Add to Briefcase
View Summary Peregrine Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2012 Financial Results and Recent Developments
Jul 16, 2012
PDF 32.0 KB Add to Briefcase
View Summary Peregrine Announces Initiation of a Phase I Rectal Adenocarcinoma Investigator-Sponsored Trial
Jul 16, 2012
PDF 19.7 KB Add to Briefcase
View Summary Peregrine to Report Fourth Quarter and Fiscal Year 2012 Financial Results After Market Close on July 16, 2012
Jul 9, 2012
PDF 13.7 KB Add to Briefcase
View Summary Peregrine to Present at JMP Securities Healthcare Conference July 12, 2012 at 9:30 AM EDT
Jul 5, 2012
PDF 13.8 KB Add to Briefcase
View Summary Peregrine Completes Patient Enrollment in Randomized Phase II Pancreatic Cancer Trial for Bavituximab
Jun 25, 2012
PDF 18.6 KB Add to Briefcase
View Summary Avid Bioservices Announces Addition of Novel Bacteriophage Production System at Upcoming BIO Conference as Part of a Collaboration With Phage Pharmaceuticals
Jun 11, 2012
PDF 13.9 KB Add to Briefcase
View Summary Peregrine Announces Positive Top-Line Data From Randomized, Double-Blind Bavituximab Phase II Trial in Second-Line Non-Small Cell Lung Cancer
May 21, 2012
PDF 20.5 KB Add to Briefcase
View Summary Researchers Present Data Highlighting Potential of Peregrine's PS-Targeting Antibodies to Treat Ocular Herpes Infections and Macular Degeneration
May 10, 2012
PDF 19.1 KB Add to Briefcase
View Summary Peregrine's Novel PS-Targeting Technology Platform to Be Highlighted at The New York Academy of Sciences Symposium on May 1, 2012
Apr 26, 2012
PDF 17.6 KB Add to Briefcase
View Summary Promising Clinical Data in Breast and Liver Cancers Further Expand the Broad Therapeutic Potential of Peregrine's Bavituximab
Apr 4, 2012
PDF 23.5 KB Add to Briefcase
View Summary Peregrine Launches PS-Targeting Clinical Imaging Program
Apr 3, 2012
PDF 19.3 KB Add to Briefcase
View Summary AVID Bioservices Highlights Antibody Engineering, Expression and Bioassay Expertise at AACR
Apr 2, 2012
PDF 17.9 KB Add to Briefcase
View Summary Promising Data Presented at AACR Further Support New Lung Cancer Treatment Combination as Well as Ongoing Studies of Peregrine's Bavituximab
Apr 2, 2012
PDF 22.0 KB Add to Briefcase
View Summary Peregrine Pharmaceuticals Announces Receipt of Notice From NASDAQ
Mar 28, 2012
PDF 14.5 KB Add to Briefcase
View Summary Peregrine Pharmaceuticals Reports Third Quarter Fiscal Year 2012 Financial Results and Recent Developments
Mar 9, 2012
PDF 28.3 KB Add to Briefcase
View Summary Peregrine Reports Data From Phase II Front-Line Lung Cancer Trial
Mar 9, 2012
PDF 19.8 KB Add to Briefcase
Showing 41-60 of 517 Page: 1 2 3 4 5 6 7 ... 26 Previous 20 | Next 20
Add to Briefcase = add release to Briefcase
Print E-mail